RENAE WELHOUSE: Open Payments
NPI 1841847688 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 12 payments from 5 companies in 2025. Trend: 2023 $268 · 2024 $178 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $78 |
| Gilead Sciences, Inc. | 3 | $50 |
| BridgeBio Pharma, Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $38 |
| ABBVIE INC. | 1 | $23 |
Products named: ELIQUIS, Veklury, Attruby, DALVANCE, Ozempic.
Industry payments across ND — which companies pay providers there.
